Reduction of the electrocardiographic qt interval for...

Details Reduction of the electrocardiographic qt interval for... Reduction of the electrocardiographic qt interval for...

A - Human Necessities

61

K

A61K 38/28 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2422026

The present invention relates to the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the OTc interval and the use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing the risk of sudden death or 'dead in bed' syndrome; particularly in patients suffering from IDDM.

La présente invention concerne l'utilisation du peptide-C de la proinsuline ou une variante, un dérivé ou un fragment de ce dernier dans la fabrication d'un médicament permettant de réduire l'intervalle QT de l'électrocardiogramme. L'invention a aussi pour objet l'utilisation du peptide C de la proinsuline ou une variante, un dérivé ou un fragment de ce dernier dans la fabrication d'un médicament permettant de réduire le risque de mort subite ou syndrôme de mort subite du nourisson, en particulier, chez les patients souffrant de diabète insulino-dépendant.

Affiliated with

Also associated with

Rating

Reduction of the electrocardiographic qt interval for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Reduction of the electrocardiographic qt interval for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduction of the electrocardiographic qt interval for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2072740